US Edition
Allergan Awarded $56M Verdict Against Revance - Orange County Business Journal
Summary by ocbj.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Allergan Awarded $56M Verdict Against Revance - Orange County Business Journal
Allergan Aesthetics, the aesthetics unit of AbbVie Inc., was awarded $56 million in a patent infringement verdict against Nashville-based Revance Therapeutics. A Delaware federal jury on July 18 found that Revance’s Daxxify infringed patents for Allergan’s Botox. Daxxify, a competing product to Botox, is an injection intended to help reduce the appearance of wrinkles and frown lines. The verdict comes four years after Allergan first sued Revance…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
